Personalized GLP-1 Injectable

Compounded GLP-1 Therapy (Semaglutide)

Semaglutide is a GLP-1 receptor agonist that works on appetite-regulation pathways in the body. This once-weekly compounded injectable is available following an online medical consultation, with dosing determined and adjusted by a licensed provider based on your individual evaluation.

Personalized plan, not a one-size-fits-all dose — your provider titrates based on your response.

Provider-supervised titration and follow-ups throughout treatment.

Medication shipped monthly directly from a U.S.-licensed pharmacy.

Compounded medications are not FDA-approved. The FDA does not review compounded products for safety, effectiveness, or quality.

How It Works

Complete a private online intake, get reviewed by a licensed provider, and receive your personalized plan — shipped monthly from a U.S.-licensed pharmacy.

Frequently Asked Questions

  • No. Compounded semaglutide is not FDA-approved, and the FDA does not review compounded products for safety, effectiveness, or quality. It’s prepared by a licensed pharmacy and prescribed only after an online medical consultation.

  • After you complete a short online intake, a licensed provider reviews your health history and goals to determine whether this program is clinically appropriate for you.

  • Yes. Your subscription can be canceled at any time — there’s no long-term commitment required.

  • A licensed provider reviews your intake, typically within 1-2 business days. If appropriate, they’ll prescribe your personalized plan, which ships monthly from a U.S.-licensed pharmacy. If it’s not a fit, you’ll be notified and won’t be charged.

  • Most compounded weight-management programs are not billed to insurance. Your intake and provider consultation costs are outlined before you begin, with transparent, all-inclusive pricing.